Heart arrhythmia, also known as irregular heartbeat or cardiac dysrhythmia, is a group of conditions where the heartbeat is irregular, too slow, or too fast. Arrhythmias are broken down into: Slow heartbeat: bradycardia. Fast heartbeat: tachycardia. Irregular heartbeat: flutter or fibrillation.
Definition of arrhythmia - background on cardiac physiology including conduction in heart - action potential - pathogensis of arrhythmia - causes and risk factors for arrhythmia- diagnosis of arrhythmia - symptoms of tachyarrhythmias and bradyarrhythmias - investigations for arrhythmia - treatment of arrhythmia - pharmacological and other modalities of therapy for arrhythmia - managment of different types of arrhythmias
Heart arrhythmia, also known as irregular heartbeat or cardiac dysrhythmia, is a group of conditions where the heartbeat is irregular, too slow, or too fast. Arrhythmias are broken down into: Slow heartbeat: bradycardia. Fast heartbeat: tachycardia. Irregular heartbeat: flutter or fibrillation.
Definition of arrhythmia - background on cardiac physiology including conduction in heart - action potential - pathogensis of arrhythmia - causes and risk factors for arrhythmia- diagnosis of arrhythmia - symptoms of tachyarrhythmias and bradyarrhythmias - investigations for arrhythmia - treatment of arrhythmia - pharmacological and other modalities of therapy for arrhythmia - managment of different types of arrhythmias
Wolff–Parkinson–White syndrome (WPW) is one of several disorders of the conduction system of the heart that are commonly referred to as pre-excitation syndromes. WPW is caused by the presence of an abnormal accessory electrical conduction pathway between the atria and the ventricles. Electrical signals traveling down this abnormal pathway (known as the bundle of Kent) may stimulate the ventricles to contract prematurely, resulting in a unique type of supra-ventricular tachycardia referred to as an atrio-ventricular reciprocating tachycardia.
Non infarction Q waves
Precise guide for Allied Health Science Students especially cardiac specialty students, DGNM, B.Sc Nursing & M.Sc Nursing Students regarding Non Infarction Q waves
Wolff–Parkinson–White syndrome (WPW) is one of several disorders of the conduction system of the heart that are commonly referred to as pre-excitation syndromes. WPW is caused by the presence of an abnormal accessory electrical conduction pathway between the atria and the ventricles. Electrical signals traveling down this abnormal pathway (known as the bundle of Kent) may stimulate the ventricles to contract prematurely, resulting in a unique type of supra-ventricular tachycardia referred to as an atrio-ventricular reciprocating tachycardia.
Non infarction Q waves
Precise guide for Allied Health Science Students especially cardiac specialty students, DGNM, B.Sc Nursing & M.Sc Nursing Students regarding Non Infarction Q waves
This ppt briefly describes reading an ECG and abnormalities of the conduction system, such as the degrees of heart block, and both left and right bundle branch block. Along with some cases for further reference and discussion of the case.
to read the ECG, we start by checking the rhythm, rate, axis, P wave, PR interval, Q wave, QRS complex, QT interval, ST segment, and T wave.
IDENTIFICATION AND APPROACH TO BRADYARRHYTHMIAS .pptxDr Dravid m c
Explanation of SA Nodal and AV nodal block , ECG changes , identification clinical features and presentation of patients to emergency department, their approach and medical linea of treatment
Seminar presentation by 5th-year medical students under the supervision of in house lecturer. He was previously working as a consultant surgeon in Syria. Reference as mentioned in the slides.
Seminar presentation by 5th year Medical Student under the supervision of a pediatric surgery specialist from HRPZ II. Reference as mentioned in the slide.
Seminar presentation by group C 5th year medical student under supervision Dato Imi, endocrine specialist in HRPZ II.
Reference as mentioned at the end of the slide presentation
4th year medical student's seminar presentation under supervision of orthopedic lecturer. Reference is from Dr. Sameh Doss Textbook of upper and lower limb, and also other multiple websites.
Seminar presentation by 4th year medical student of Lincoln University College, supervised by HRPZ Orthopedic's specialist.
Reference were from reliable medical websites and also from texttbook; Apley and Solomon's Concise System of Orthopaedics and Trauma, 4th Ed.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
8. ARRHYTHMIAS
ELEMENTS OF ECG
Relationship between P and QRS helps distinguish various cardiac arrhythmias
Shape and duration of P may indicate atrial enlargement
Normal duration = 0.12 – 2.0 sec (120 – 200ms) (3 – 4 horizontal boxes
Represents atria to ventricular conduction time (through His bundle)
Prolonged PR interval may indicate 1st degree heart block
Larger than P wave because of greater muscle mass of ventricles
Normal duration = 0.08 – 0.12 second
Its duration, amplitude and morphology are useful in diagnosing cardiac
arrhythmias, ventricular hypertrophy, MI, electrolyte derangement, etc.
Q-wave greater than 1/3 the height of the R-wave, greater than 0.4 sec are
abnormal mad may represent MI.
P-WAVE: DEPOLARIZARION OF BOTH ATRIA
PR INTERVAL: FROM ONSET OF P WAVE TO ONSET OF QRS
QRS COMPLEX: VENTRICULAR DEPOLARIZATION
9. PATHOGENESIS
AND INDUCEMNET OF ARRHYTHMIA
Some physical condition
Pathological heart disease
Other system disease
Electrolyte disturbance and acid-base imbalance
Physical and chemical factors or toxicosis
13. TREATMENT STRATEGY
HOW TO RECOGNIZE ARRHYTHMIA?
First assess the patient and check their pulse
Are they compromised?
Low BP, impaired consciousness, heart failure, chest pain
Then assess the ECG
Is there high risk of cardiac arrest?
VT, complete heart block
If compromised or high risk
Treat with electricity
DC cardioversion / temporary pacing
If not
Look for reversible causes / treat with drugs
18. HEART BLOCK
Heart block, AV bundle or bundle branch block affects the
electrical system of the heart.
It is different from coronary artery disease, which affects
the heart’s blood vessels.
The heart beats irregularly and more slowly than usual,
potentially stopping for up to 20 seconds at a time.
A heart block makes it difficult for the heart to pump
blood properly through the circulatory system, so the
muscles and organs do not get enough oxygen to function
properly.
Heart block itself does not usually need direct treatment,
but related underlying health conditions do.
19. FIRST – DEGREE HEART BLOCK
First degree heart block is actually a delay rather than a block.
It involves minor heartbeat disruptions, such as skipped beats.
If each wave of depolarization that originates in the SA node is conducted to
the ventricles, but there is delay somewhere along the conduction pathway, the
the PR interval is prolonged.
This means than the PR interval will be longer than normal (over 0.20 seconds)
It does not generally require treatment.
First degree heart block is not itself important, but it may be a sign of coronary
artery disease, acute rheumatic carditis, digoxin toxicity or electrolyte
disturbances.
TYPES OF HEART BLOCK
20. SECOND – DEGREE HEART BLOCK
Sometimes excitation completely fails to pass through the AV node or the
bundle of His. When this occurs intermittently, second degree heart
block is said to exist.
There are 3 variations of this:
I. Most beats are conducted with a constant PR interval, but
occasionally there is an atrial contraction without a subsequent
ventricular contractions – Mobitz Type II phenomenon
II. There may be progressive lengthening of the PR interval and then
failure of conduction of an atrial beat , followed by a conducted
beat with a shorter PR interval and then a repetition of this cycle –
Wenckebach phenomenon
III. There may be alternate conducted and non-conducted atrial beats
(or one conducted atrial beat and then two non-conducted beats),
giving twice (or three times) as many P waves as QRS complex – 2:1
conduction
TYPES OF HEART BLOCK
21. SECOND – DEGREE HEART BLOCK TYPE I
Some impulses are blocked but not all.
More P waves can be observed vs QRS complexes on a tracing.
Each successive impulse undergoes a longer delay. After 3 or 4 beats
the next impulse is blocked.
On a EKG tracing, PR intervals will lengthen progressively with each
beat until a QRS complex is missing.
After this blocked beat, the cycle of lengthening PR intervals resumes.
This heart block is also called a Wenckebach block.
TYPES OF HEART BLOCK
22. SECOND – DEGREE HEART BLOCK TYPE II
With Mobitz Type II blocks, the impulse is blocked in the bundle of
His
Every few beats there will be a missing beat but the PR interval will
not lengthen
TYPES OF HEART BLOCK
24. THIRD – DEGREE HEART BLOCK
With this block, it is said to occur when atrial contraction is normal
but no beats are conducted to the ventricles.
As a result, the ventricles generate an escape impulse, which is
independent of the atrial beat.
Complete block is not always immediately obvious in a 12 lead
ECG, where there may be only a few QRS complexes per lead. Ones
need to look at the PR interval in all the leads.
In most cases the atria will beat at 60 – 100 bpm while the
ventricles asynchronously beat at 30 – 45 bpm
It is more common in patients with heart disease.
May occur as an acute phenomenon in patients with MI or it may
be a chronic state, usually due to fibrosis around the bundle of His.
It may also be caused by the block of both bundle branches.
TYPES OF HEART BLOCK
26. THIRD – DEGREE HEART BLOCK
TYPES OF HEART BLOCK
Sinus rhythm but no P waves are conducted
Right axis deviation
Broad QRS complexes (duration 160 ms)
Right bundle branch block pattern
The cause of the block could not be determined, though in most patients it results
from fibrosis of bundle of His
27. BUNDLE BRANCH BLOCK
If the depolarization wave reaches the interventricular septum
normally, the interval between the beginning of the P wave and the
first deflection in QRS complex will be normal.
However, if there is abnormal conduction through either the right
of left bundle branches, (‘bundle branch block’) there will be a
delay in the depolarization of part of the ventricular muscle.
The extra time taken for depolarization of the whole of the
ventricular muscle causes widening of the QRS complex.
Although a wide QRS complex can indicate BBB, widening also
occurs if depolarization begins within the ventricular muscle itself.
Remember in the sinus rhythm with bbb, normal P waves are
present with a constant PR interval.
TYPES OF HEART BLOCK
28. BUNDLE BRANCH BLOCK
Block of the bundle branches has the same effect as block of His
bundle, and causes complete heart block.
right bundle branch block (RBBB) often indicates problems in the
right side of heart but RBBB patterns with a QRS complex of normal
duration are quite common in healthy people.
Left bundle branch block (LBBB) is always an indication of heart
disease, usually of the left side.
It is important to recognize that bundle branch block is present
because LBBB prevents any further interpretation of the
cardiogram, and RBBB can make interpretation difficult.
TYPES OF HEART BLOCK
29. BUNDLE BRANCH BLOCK
The mechanism underlying the ECG patterns of RBBB and LBBB can
be worked out from the first principles.
1. The septum is normally depolarized from left to right
2. The left ventricle, having the greater muscle mass, exerts
more influence on ECG than does the right ventricle
3. Excitation spreading towards a lead causes an upward
deflection within the ECG
TYPES OF HEART BLOCK
30. RIGHT BUNDLE BRANCH BLOCK
No conduction occurs down the right bundle branch but the
septum is depolarized from the left side as usual, causing an R
wave in a right ventricular lead (V1) and a small Q wave in a left
ventricular lead (V6)
TYPES OF HEART BLOCK
33. LEFT BUNDLE BRANCH BLOCK
If conduction down the left bundle branch fails, the septum
becomes depolarized from right to left, causing a small Q wave in
lead V1 and R wave in lead V6
TYPES OF HEART BLOCK
38. WHAT TO DO
Always remember that it is the patient who should be treated , not
the ECG
Relief the symptoms always comes first
However, some general points can be made about the action that
might be taken if the ECG shows conduction abnormalities
FIRST DEGREE BLOCK
Often seen in normal people
Think about acute myocardial infarction and acute rheumatic fever
as possible causes
No specific action needed
39. WHAT TO DO
SECOND DEGREE BLOCK
Usually indicates heart disease; often seen in acute myocardial
infarction
Mobitz Type II and Wenckebach block do not need specific
treatment
2:1 block may indicate a need for temporary or permanent pacing,
especially if the ventricular rate is slow
THIRD DEGREE BLOCK
Always indicates conducting tissue disease – more often fibrosis
than ischemic
Consider a temporary or permanent pacemaker
40. WHAT TO DO
RIGHT BUNDLE BRANCH BLOCK
Think about an atrial septal defect
No specific treatment
LEFT BUNDLE BRANCH BLOCK
Think about aortic stenosis and ischemic disease
If the patient is asymptomatic, no action is needed
If the patient has recently had severe chest pain, LBBB may
indicate an acute myocardial infarction and thrombolysis should be
considered
42. Here’s how patients have described their experience:
“My heart flip-flops, skips beats, and feels like it’s
banging against my chest wall, especially if I’m
carrying stuff up my stairs or bending down.”
“I was nauseated, light-headed, and weak. I had a
really fast heartbeat and felt like I was gasping for
air.”
“I had no symptoms at all. I discovered my AF at a
regular check-up. I’m glad we found it early.”
ATRIAL FIBRILLATION
43. ATRIAL FIBRILLATION
Atrial fibrillation (also called AFib or AF) is an atrial
tachyarrhythmia characterized by uncoordinated atrial
activation with consequent deterioration of atrial
mechanical function.
The surface ECG is characterized by ‘absolutely’
irregular RR intervals and the absence of any distinct P
waves. The P waves are replaced by fibrillary waves.
Atrial fibrillation is the commonest sustained cardiac
arrhythmia and also a major cause of stroke.
The mortality rate of AF is double that of patient in
sinus rhythm
47. TERMINOLOGY CLINICAL FEATURES PATTERN
Initial event (first
detected episode)
Symptomatic
Asymptomatic
Onset Unknown
May or may not recur
Paroxysmal Spontaneous
termination <7 days
and most often <48
hour
Recurrent
Persistent No self limiting
Lasting >7 days or
requiring
cardioversion for
termination
Recurrent
Long Standing Persistent AF that has lasted for
1 year when it is
decided to adopt
rhythm control
strategy
Recurrent
Permanent Not terminated
Terminated but
relapsed
No cardioversion
attempt
Recurrent
48. ATRIAL FIBRILLATION
The term lone AF applies to young individuals
(<60 years of age) or echocardiography evidence
of cardiopulmonary disease, including
hypertension. These patient has favorable
prognosis with respect to thromboembolism and
mortality.
‘Silent AF’ being asymptomatic is detected by an
opportunistic ECG or may present as an AF-
related complication such as ischemic stroke.
49. INITIAL MANAGEMENT
Clinical Management of AF patients should
concentrate on:
Relief of symptoms
Assessment of AF-associated risk
Determination of EHRA score
Estimation of stroke risk
Search for conditions that predispose to AF
Search for complications of the arrhythmia
51. EHRA SCORING SYSTEM
The EHRA symptom score provides a simple clinical tool for
assessing symtoms during AF. The score only considers
symptoms that are attributable to AF and reverse or reduce
upon restoration of sinus rhythm or with effective rate
control.
52. CHADS2-VASc
Estimation of stroke risk
Maximum total score = 9
Score:
0 – No need therapy preferred
1 – Aspirin or Oral anti-coagulation
≥2 – Oral anti-coagulation
54. DETECTION
Those with undiagnosed AF can receive treatment sooner if an
opportunistic case finding is undertaken. Routine palpation of the
radial pulse (not less than 20 seconds) during screening of blood
pressure will be a good opportunity to pick up undiagnosed atrial
fibrillation.
In patients presenting with any of the following:
Breathlessness
Palpitations
Syncope/dizziness
Chest discomfort or stroke/TIA
Manual pulse palpation should be performed to assess for the
presence of an irregular pulse that may indicate AF.
55. DETECTION
The diagnosis of AF requires confirmation by ECG,
sometimes in the form of bedside telemetry,
ambulatory Holter recordings and event loop
recordings.
If AF is presented at the time of recording, a
standard 12-lead ECG is sufficient to confirm the
diagnosis.
In paroxysmal AF, 7 days Holter ECG recording or
daily and symptom-activated event recordings
may document the arrhythmia in 70% of AF
patients.
67. COMPLICATIONS
Stroke.
In atrial fibrillation, the chaotic rhythm may cause blood to pool in the
atrium and form clots. If a blood clot forms, it could dislodge from the
heart and travel to the brain. There it might block blood flow, causing a
stroke.
The risk of a stroke in atrial fibrillation depends on the age (you have a
higher risk as you age) and on whether they have high blood pressure,
diabetes, a history of heart failure or previous stroke, and other
factors.
Certain medications, such as blood thinners, can greatly lower the risk
of a stroke or the damage to other organs caused by blood clots.
Heart failure. Atrial fibrillation, especially if not controlled, may
weaken the heart and lead to heart failure.
68. SUMMARY
An ECG should be performed in all patients, whether
symptomatic or not, in whom AF is suspected because
an irregular pulse has been detected.
The stroke risk stratification algorythms, CHADS2 and
CHA2DS2-VASC, should be used in patients with AF to
assess their risk of stroke and thromboembolism, while
the HAS-BLED score should be assess their risk of
bleeding.
Antithrombotic therapy should be based upon the
absolute risks of stroke/thromboembolism and
bleeding, and the relative risk and benefit for a given
patient
69. SUMMARY
In patient with permanent AF, who need
treatment for rate control, beta blockers or
rate limiting calcium antagonist should be the
preferred initial monotherapy in all patients
while digoxin should only be considered as
monotherapy in predominantly sedentary
patients.
70. SINUS TACHYCARDIA
The normal adult heart rate, arising from the sinoatrial (SA) node,
range from 60 to 100 bpm.
Sinus tachycardia = a sinus rhythm with a rate exceeding 100 bpm
Sinus tachycardia is a rhythm in which the rate of impulses arising from
the sinoatrial (SA) node is elevated.
It is one of the most commonly encountered, and often overlooked,
rhythm disturbances that may portend an adverse prognosis, particularly
in patients with cardiovascular disease.
Rapid rates, though they may be compensating for ischemia elsewhere,
increase myocardial oxygen demand and reduce coronary blood flow,
thus precipitating an ischemic heart or valvular disease.
Sinus tachycardia accompanying a myocardial infarction may be
indicative of cardiogenic shock.
71. SINUS TACHYCARDIA
PHARMACOLOGICAL PHARMACOLOGICAL
Exercise Beta Agonist : adrenaline, isoprenaline,
salbutamol, dobutamine
Pain Sympathomimetics: amphetamines,
cocaine, methylphenidate
Hypoxia Antimuscarinics: antihistamines,
carbamazepine, atropine
Anxiety Other stimulants: caffeine, nicotine,
amphetamines
Hyperthyroidism
Acute coronary ischemia and myocardial
infarction
Sinus tachycardia is a normal physiologic response to exercise and conditions in
which catecholamine release is physiologically enhanced or, less commonly, in
situations where the parasympathetic nervous system is withdrawn. A long list of
other factors may be responsible in selected cases, including:
72. SINUS TACHYCARDIA
Sinus tachycardia as a Physiologic
Response
In the majority of patients, sinus tachycardia is a physiologic response
to a demand for greater cardiac output, increased sympathomimetic
state, or vagal/parasympathetic withdrawal.
Important mechanism for increasing cardiac output in the setting of
infection or volume depletion.
Because of this, most patients do not have symptoms directly
attributable to the tachycardia itself but present with signs or
symptoms related to the associated condition (eg, pain, fever,
shortness of breath, etc).
73. SINUS TACHYCARDIA
Sinus tachycardia as a Physiologic
Response
Sinus tachycardia can indirectly lead to other symptoms due to the impact of
the tachycardia on other underlying organic heart disease. Tachycardia may
result in:
I. Decreased cardiac output due to shortened ventricular filling time
II. Increased myocardial oxygen consumption
III. Reduced coronary blood flow
The above physiologic changes induced by tachycardia may result in symptoms
of angina or dyspnea, the severity of which will depend upon how rapidly the
heart is beating and the extent of the underlying cardiac comorbidities.
74. SINUS TACHYCARDIA
Postural Orthostatic Tachycardia Syndrome
Postural orthostatic tachycardia syndrome (POTS) is a condition that occurs
predominantly in young women in the absence of structural heart disease.
It is the most common syndrome of young people seen in autonomic
dysfunction clinics. Patients present at a relatively young age (14 to 45 years).
Characteristically, patients develop symptoms upon assuming the standing
position.
Symptoms may include palpitations, fatigue, lightheadedness, or exercise
intolerance.
The 2015 Heart Rhythm Consensus statement defined POTS as a heart rate rise
of ≥30 beats per minute (≥40 beats per minute in individuals 12 to 19 years of
age) in the absence of orthostatic hypotension (≥20 mmHg systolic blood
pressure drop).
Sinus tachycardia is only one component of this condition, which is a disorder
of autonomic dysregulation
75. SINUS TACHYCARDIA
Inappropriate sinus tachycardia
Inappropriate sinus tachycardia, also called chronic non-paroxysmal sinus tachycardia,
is an unusual condition that occurs in individuals without apparent heart disease or
other cause for sinus tachycardia, such as hyperthyroidism or fever, and is generally
considered a diagnosis of exclusion.
Inappropriate sinus tachycardia is defined as a resting heart rate >100 beats per minute
(with a mean heart rate >90 beats per minute over 24 hours) associated with highly
symptomatic palpitations.
Commonly used criteria to define inappropriate sinus tachycardia include:
P wave axis and morphology similar or identical to sinus rhythm.
Resting heart rate of 100 beats per minute or greater (with a mean heart rate >90
beats per minute over 24 hours) or with activity heart rates of 100 beats per
minute or greater but in excess of what one would expect for the amount of
exertion.
76. SINUS TACHYCARDIA
Inappropriate sinus tachycardia
Palpitations, presyncope, or both related to the
tachycardia. Very rarely do patients experience
syncope.
Exclusion of identifiable causes of sinus tachycardia.
Exclusion of atrial tachycardia.
Most of these patients are young and female.
Affected patients have an elevated resting heart rate
and/or an exaggerated heart rate response to exercise
that is out of proportion to the body's physiological
needs; many patients have both.
77. SINUS TACHYCARDIA
Inappropriate sinus tachycardia
Patients with inappropriate sinus tachycardia are usually
symptomatic and have resting heart rates of greater than
100 beats per minute and average heart rates on a 24-
hour Holter greater than 90 beats per minute with no
clear physiologic, pathologic, or pharmacologic trigger.
The pathophysiologic mechanism behind this disease is
poorly understood and is thought to consist of intrinsic
sinus node hyperactivity coupled with autonomic
disturbance modulated by neurohormonal influences.
One study suggested that this tachycardia is related to a
primary sinus node abnormality, characterized by a high
intrinsic heart rate, depressed efferent cardiovagal
reflex, and beta-adrenergic hypersensitivity.
78. With very fast heart rates the P waves may be hidden in the preceding T wave, producing a ‘camel
hump’ appearance.
Life In the Fastlane
79. SUPRAVENTRICULAR
TACHYCARDIA
Any tachyarrhythmia arising from above the level of the Bundle of His.
ATRIAL TACHYARRHYTHMIA
JUNCTIONAL ARRHYTHMIA
1. Atrial tachycardia
2. Atrial flutters
3. Atrial fibrillation
1. AV nodal reentrant tachycardia
2. AV nodal reciprocating tachycardia – Wolff-
Parkinson-White syndrome
80. BILIARY ATRESIA
REGULAR IRREGULAR
ATRIAL
Sinus tachycardia
Atrial tachycardia
Atrial flutter
Atrial fibrillation
ATRIOVENTRICULAR (AV)
Atroventricular re-entry
tachycardia (AVRT)
AV nodal re-entry
tachycardia (AVNRT)
SUPRAVENTRICULAR
TACHYCARDIA
Classification by site and regularity
81. ATRIAL FLUTTER
Atrial flutter is a common abnormal heart rhythm,
similar to atrial fibrillation, the most common
abnormal heart rhythm. Both conditions are types of
supraventricular (above the ventricles) tachycardia
(rapid heart beat).
In atrial flutter, the upper chambers (atria) of the heart
beat too fast (re-entrant mechanism), which results in
atrial muscle contractions that are faster than and out
of sync with the lower chambers (ventricles).
82. ATRIAL FLUTTER
QRS Complex Present
Rhythm Regular
Ventricular rhythm often regular
Set ratio atrial rhythm e.g. 2 to 1
P Wave No true P waves
Flutter waves in “sawtooth” pattern
83. ATRIAL FLUTTER
General treatment goals for symptomatic atrial flutter are
similar to those for atrial fibrillation and include the
following:
1. Control of the rate
2. Restoration of sinus rhythm
3. Prevention of recurrent episodes or reduction of their
frequency or duration
4. Prevention of thromboembolic complications
5. Minimization of adverse effects from therapy
84. AVRT
ATRIOVENTRICULAR RE-ENTRANT
TACHYCARDIA
Most associated with Wolff-Parkinson-White syndrome
in which as accessory pathway allows electrical signals
from the heart’s ventricles to enter the atria and cause
earlier then normal contraction, which leads to
repeated stimulation of the AV node
85. AVRT
ATRIOVENTRICULAR RE-ENTRANT
TACHYCARDIA
Wolff-Parkinson-White Syndrome
First described in 1930 by Louis Wolff, John Parkinson and Paul
Dudley White.
Wolff-Parkinson-White (WPW) Syndrome is a combination of the
presence of a congenital accessory pathway and episodes of
tachyarrhythmia.
Incidence 0.1 – 3.0 per 1000.
Associated with a small risk of sudden cardiac death.
87. TREATMENT
ATRIOVENTRICULAR RE-ENTRANT
TACHYCARDIA
The aim is to interrupt the circuit.
1. Inhibition of AV node – vagal maneuvre to slow
down heart rate
2. IV adenosine – complete electrival blockade at AV
node and interrupt the reentrant electrical circuit.
3. Radiofrequency ablation of accessory pathway
88. AVNRT
ATRIOVENTRICULAR NODAL RE-ENTRANT
TACHYCARDIA
Atrioventricular Nodal Reentrant Tachycardia is a type of
supraventricular tachycardia (i.e it originates above the level
of the Bundle of His) and is the commonest cause of
palpitations in patients with hearts exhibiting no structurally
abnormality.
AV nodal reentrant tachycardia is the most common regular
supraventricular tachycardia.
It is more common in women than men (approximately 75%
of cases occur in females).
89. AVNRT
ATRIOVENTRICULAR NODAL RE-ENTRANT
TACHYCARDIA
Atrioventricular Nodal Reentrant Tachycardia is a type of
supraventricular tachycardia (i.e it originates above the level of the
Bundle of His) and is the commonest cause of palpitations in patients with
hearts exhibiting no structurally abnormality.
AV nodal reentrant tachycardia is the most common regular
supraventricular tachycardia.
It is more common in women than men (approximately 75% of cases
occur in females).
The circuit usually involves two anatomical pathways: the fast pathway
and the slow pathway, which are both in the right atrium. The slow
pathway is located inferior and slightly posterior to the AV node.
92. AVNRT
ATRIOVENTRICULAR NODAL RE-ENTRANT
TACHYCARDIA
Absent P waves, or inverted P waves after the QRS complex
Narrow (<120 ms) QRS complex
Heart rate 140-250 bpm, with a regular rhythm
Can occur in the young and healthy
Three quarters of patients are female
93. TREATMENT
ATRIOVENTRICULAR NODAL RE-ENTRANT
TACHYCARDIA
1. Vagal maneuvers
2. Medication
Adenosine, beta blockers or calcium channel blockers
3. Cardioversion
In very rare instances, cardioversion (the electrical restoration of a normal heart
rhythm) is needed in the treatment of AVNRT. This would normally only happen if all
other treatments have been ineffective, or if the fast heart rate is poorly tolerated
(e.g. the development of heart failure symptoms, low blood pressure or coma).
4. Electrophysiology
After being diagnosed with AVNRT, patients can also undergo an Electrophysiology
(EP) study to confirm the diagnosis. Catheter ablation of the slow pathway, if
successfully carried out, can potentially cure the patient of AVNRT.
94. VENTRICULAR TACHYCARDIA
Can be defined as three or more premature ventricular contraction in a row
The impulse is iniatiated from the ventricle itself.
Rate is 150-250, regular rhythm and wide QRS
a/w coronary artery disease, myocardial infarction, electrolyte imbalace,
myocardiopathy
Manage depends on severity- if stable (keep on ecg monitoring), if unstable
unconcious no pulse ( immediate defibrillationt, iv amiodarone)
95. VENTRICULAR FIBRILLATION
Rapid disorganized ventricular rhythm that results of inactive
activities of the ventricles, absence of audible heartbeat and
no palpable pulse.
No atrial activity seen ,rate and rhythm cannot be determined
a/w acute MI, untreated ventricular tachycardia, electrical
shock, drug overdose
Manage with immediate defibrillation, CPR, iv amiodarone
96. TORSADE DE POINTES
Polymorphic ventricular tachycardia with long QT interval, rapid
irregular QRS complex.
Caused by a medication such as sotalol, procanamaide, quinidine,
hypokalemia, bradycardia after MI
If acute, remove offending medication, shorten QT interval with
magnesium sulphate, isoprterenol.
If chronic, pacemaker, amiodarone and beta blocker.